Springer Timothy A

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
18-Nov-24 7:35 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 18-Nov-24Purchase 58,295$18.12$1,056,180.00< 1%
9.26M to 9.32M
18-Nov-24 7:35 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 15-Nov-24Purchase 277,246$17.09$4,739,190.003%
8.98M to 9.26M
18-Nov-24 7:35 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 14-Nov-24Purchase 96,399$16.37$1,578,160.001%
8.88M to 8.98M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 04-Oct-24Purchase 80,301$22.58$1,813,010.00< 1%
8.8M to 8.88M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 03-Oct-24Purchase 119,906$19.89$2,384,710.001%
8.68M to 8.8M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Oct-24Acquisition (other) 1,801,310----21%
8.68M to 10.48M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Oct-24Acquisition (other) 317,879----3%
10.48M to 10.8M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Oct-24Disposition (other) 2,119,190----(20%)
10.8M to 8.68M
04-Oct-24 5:58 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Oct-24Purchase 5,514$17.38$95,821.70< 1%
10.8M to 10.8M
26-Sep-24 6:15 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 26-Sep-24Purchase 50,000$28.82$1,440,830.001%
4.24M to 4.29M
27-Sep-24 4:13 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 25-Sep-24Option Exercise 1,636,830----19%
8.68M to 10.32M
27-Sep-24 4:13 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 25-Sep-24Option Exercise 722,668----7%
10.32M to 11.04M
27-Sep-24 4:13 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 25-Sep-24Option Exercise 1,636,830----(15%)
11.04M to 9.4M
27-Sep-24 4:13 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 25-Sep-24Option Exercise 722,668----(8%)
9.4M to 8.68M
26-Sep-24 6:15 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 24-Sep-24Acquisition (other) 1,054,760----25%
4.24M to 5.3M
26-Sep-24 6:15 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 24-Sep-24Acquisition (other) 186,134----4%
5.3M to 5.48M
26-Sep-24 6:15 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 24-Sep-24Disposition (other) 1,240,890----(23%)
5.48M to 4.24M
20-Aug-24 7:10 PM
View: 
Morphic Holding, Inc. (MORF) 16-Aug-24Disposition (change in control) 4,608,050----(62%)
7.42M to 2.81M
20-Aug-24 7:10 PM
View: 
Morphic Holding, Inc. (MORF) 16-Aug-24Disposition (change in control) 2,811,770----(100%)
2.81M to 0
14-Aug-24 4:43 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 12-Aug-24Purchase 8,016$12.72$101,968.00< 1%
6.31M to 6.32M
05-Jul-24 4:02 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Jul-24Grant 1,636,830$20.00$32,736,600.0026%
6.31M to 7.95M
05-Jul-24 4:02 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Jul-24Grant 722,668$20.00$14,453,400.009%
7.95M to 8.67M
24-Jun-24 4:30 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 20-Jun-24Grant 2,692,000----100%
0 to 2.69M
24-Jun-24 4:30 PM
View: 
Tectonic Therapeutic, Inc. (TECX) 20-Jun-24Grant 1,551,120----58%
2.69M to 4.24M
10-Apr-24 9:40 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 08-Apr-24Option Exercise 4,130,850----275%
1.5M to 5.63M
10-Apr-24 9:40 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 08-Apr-24Option Exercise 826,169----15%
5.63M to 6.46M
10-Apr-24 9:40 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 08-Apr-24Option Exercise 123,925----(2%)
6.46M to 6.34M
10-Apr-24 9:40 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 08-Apr-24Option Exercise 24,785----(< 1%)
6.34M to 6.31M
26-Mar-24 4:32 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 26-Mar-24Option Exercise 1,970,440$1.46$2,876,850.005%
38.63M to 40.6M
20-Mar-24 5:09 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 18-Mar-24Private Purchase 19,044$0.60$11,397.80< 1%
38.61M to 38.63M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 18-Mar-24Purchase 800$0.61$488.00< 1%
40.62M to 40.62M
18-Mar-24 5:29 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 15-Mar-24Purchase 537,500$0.59$314,545.001%
38.07M to 38.61M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 15-Mar-24Purchase 1,200$0.56$672.00< 1%
40.62M to 40.62M
18-Mar-24 5:29 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 14-Mar-24Private Purchase 648,372$0.54$351,677.002%
37.43M to 38.07M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 14-Mar-24Purchase 2,000$0.53$1,061.00< 1%
40.62M to 40.62M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 13-Mar-24Purchase 3,200$0.58$1,867.84< 1%
40.61M to 40.62M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 12-Mar-24Purchase 1,200$0.61$734.64< 1%
40.61M to 40.61M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 11-Mar-24Purchase 1,200$0.65$784.92< 1%
40.61M to 40.61M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 08-Mar-24Purchase 4,800$0.66$3,186.72< 1%
40.61M to 40.61M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 07-Feb-24Purchase 2,400$0.66$1,575.12< 1%
40.6M to 40.61M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 06-Feb-24Purchase 800$0.65$520.00< 1%
40.6M to 40.6M
28-Mar-24 5:11 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 17-Jan-24Private Purchase 800$0.69$552.00< 1%
40.6M to 40.6M
04-Jan-24 5:06 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 02-Jan-24Grant 178,000----< 1%
37.25M to 37.43M
15-Nov-23 5:20 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 15-Nov-23Grant 24,785$403.47$10,000,000.00< 1%
37.25M to 37.27M
15-Nov-23 5:20 PM
View: 
Cartesian Therapeutics, Inc. (RNAC) 15-Nov-23Grant 123,925$403.47$50,000,000.00< 1%
37.27M to 37.4M
30-Jun-23 7:03 PM
View: 
Morphic Holding, Inc. (MORF) 28-Jun-23Acquisition (other) 429----< 1%
7.42M to 7.42M
30-Jun-23 7:03 PM
View: 
Morphic Holding, Inc. (MORF) 28-Jun-23Acquisition (other) 429----< 1%
7.42M to 7.42M
04-May-23 10:00 PM
View: 
Morphic Holding, Inc. (MORF) 03-May-23Market Purchase 1,050,000$45.00$47,250,000.0016%
6.37M to 7.42M
5%
13-Feb-23 4:14 PM
View: 
Morphic Holding, Inc. (MORF) 13-Feb-23Grant 42,432$35.35$1,499,970.00< 1%
5.52M to 5.56M
13-Feb-23 4:14 PM
View: 
Morphic Holding, Inc. (MORF) 13-Feb-23Grant 806,223$35.35$28,500,000.0014%
5.56M to 6.37M